Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


GRANTING BIOWAIVER FOR IMMEDIATE RELEASE SOLID ORAL DOSAGE FORMS OF AMOXICILLIN: RESULTS OF A LITERATURE REVIEW

  • In: Poster Session
  • At: Düsseldorf (Germany) (2015)
  • Type: Poster
  • By: THAMBAVITA, Dhanusha (Faculty of Medicine, University of Colombo, Pharmacology, Colombo-08, Sri Lanka)
  • Co-author(s): Dhanusha Thambavita
  • Abstract:

    Biowaiver(BW) monographs pertaining to waiving of in vivo bioequivalence(BE) are available for drugs belonging to Biopharmaceutics Classification System(BCS) class 1 and III. World Health Organization(WHO) classifies amoxicillin to BCS class 1 but no BW monograph is available as yet. We reviewed literature relevant to a BW monograph for..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses